4//SEC Filing
LIPPMAN MARC E 4
Accession 0001203311-20-000122
CIK 0001060736other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 8:44 PM ET
Size
44.3 KB
Accession
0001203311-20-000122
Insider Transaction Report
Form 4
Seagen Inc.SGEN
LIPPMAN MARC E
Director
Transactions
- Exercise/Conversion
Common Stock
2020-11-03$56.77/sh+9,260$525,690→ 140,908 total - Sale
Common Stock
2020-11-03$168.39/sh−9,260$1,559,291→ 131,648 total - Exercise/Conversion
Common Stock
2020-11-03$34.25/sh+8,750$299,688→ 140,398 total - Sale
Common Stock
2020-11-03$168.32/sh−8,750$1,472,800→ 131,648 total - Exercise/Conversion
Common Stock
2020-11-03$36.70/sh+8,750$321,125→ 140,398 total - Exercise/Conversion
Common Stock
2020-11-03$20.06/sh+4,716$94,603→ 136,364 total - Sale
Common Stock
2020-11-03$167.97/sh−4,716$792,147→ 131,648 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-11-03−9,260→ 0 totalExercise: $39.94Exp: 2025-05-14→ Common Stock (9,260 underlying) - Sale
Common Stock
2020-11-03$168.45/sh−9,260$1,559,847→ 131,648 total - Sale
Common Stock
2020-11-03$168.42/sh−9,260$1,559,569→ 131,648 total - Sale
Common Stock
2020-11-03$168.11/sh−8,750$1,470,963→ 131,648 total - Exercise/Conversion
Common Stock
2020-11-03$20.06/sh+12,784$256,447→ 144,432 total - Sale
Common Stock
2020-11-03$167.10/sh−12,784$2,136,206→ 131,648 total - Sale
Common Stock
2020-11-03$168.89/sh−65,246$11,019,397→ 66,402 total - Sale
Common Stock
2020-11-03$169.80/sh−14,064$2,388,067→ 52,338 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-11-03−4,716→ 12,784 totalExercise: $20.06Exp: 2022-05-17→ Common Stock (4,716 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-11-03−12,784→ 0 totalExercise: $20.06Exp: 2022-05-17→ Common Stock (12,784 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-11-03−8,750→ 0 totalExercise: $34.25Exp: 2024-05-15→ Common Stock (8,750 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-11-03−8,750→ 0 totalExercise: $36.70Exp: 2023-05-17→ Common Stock (8,750 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-11-03−9,260→ 0 totalExercise: $38.82Exp: 2026-05-19→ Common Stock (9,260 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2020-11-03−9,260→ 0 totalExercise: $56.77Exp: 2028-05-18→ Common Stock (9,260 underlying) - Exercise/Conversion
Common Stock
2020-11-03$38.82/sh+9,260$359,473→ 140,908 total - Exercise/Conversion
Common Stock
2020-11-03$39.94/sh+9,260$369,844→ 140,908 total
Footnotes (15)
- [F1]Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- [F10]Options were fully vested on 5/17/13.
- [F11]Options were fully vested on 5/15/15.
- [F12]Options were fully vested on 5/16/14.
- [F13]Options were fully vested on 5/19/17.
- [F14]Options were fully vested on 5/14/16.
- [F15]Options were fully vested on 5/18/19.
- [F2]Reflects sales of common stock executed in multiple transactions at prices ranging from $168.42 to $168.52. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F3]Reflects sales of common stock executed in multiple transactions at prices ranging from $168.37 to $168.42. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F4]Reflects sales of common stock executed in multiple transactions at prices ranging from $168.23 to $168.37. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F5]Reflects sales of common stock executed in multiple transactions at prices ranging from $168.04 to $168.23. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F6]Reflects sales of common stock executed in multiple transactions at prices ranging from $167.80 to $168.04. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F7]Reflects sales of common stock executed in multiple transactions at prices ranging from $166.76 to $167.62 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F8]Reflects sales of common stock executed in multiple transactions at prices ranging from $168.52 to $169.51. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F9]Reflects sales of common stock executed in multiple transactions at prices ranging from $169.61 to $170.06. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Documents
Issuer
Seagen Inc.
CIK 0001060736
Entity typeother
Related Parties
1- filerCIK 0001202794
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 8:44 PM ET
- Size
- 44.3 KB